FDA PUBLIC CALENDAR

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title	Date	Location	Other FDA Participants	Non-FDA Participants	Subject
February 23-27, 2009
Frank Torti, Acting Commissioner	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Randall Lutter, Deputy Commissioner for Policy	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs	2/24/09	Rockville, Maryland	David Elder, George Salem, Richard Garwood	Susan de Mars, Roger L. Williams, Brian Hendrix, Ken Alexander, Steve Lane (USP)	Discuss the CRADA between FDA and USP
Jesse Goodman, Director, Center for Biologics Evaluation and Research	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
William Slikker, Director, National Center for Toxicological Research	2/23/09 through 2/27/09	N/A	N/A	N/A	No significant meetings
Jeffrey M. Senger, Acting Chief Counsel	2/25/2009	FDA/Rockville	Kim Dettelbach, Julie Finegan, Eric Blumberg (OCC)	Robert Dormer, Michelle Butler (Hyman, Phelps & McNamara)	ANDA Approval Issues

horizonal rule